A detailed history of Xtx Topco LTD transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Xtx Topco LTD holds 67,182 shares of PDSB stock, worth $131,676. This represents 0.02% of its overall portfolio holdings.

Number of Shares
67,182
Previous 19,654 241.82%
Holding current value
$131,676
Previous $57,000 349.12%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.93 - $4.23 $139,257 - $201,043
47,528 Added 241.82%
67,182 $256,000
Q2 2024

Aug 12, 2024

SELL
$2.55 - $4.02 $103,530 - $163,211
-40,600 Reduced 67.38%
19,654 $57,000
Q1 2024

May 13, 2024

BUY
$3.85 - $6.59 $231,977 - $397,073
60,254 New
60,254 $238,000
Q2 2022

Aug 15, 2022

BUY
$3.05 - $6.68 $64,309 - $140,847
21,085 New
21,085 $77,000

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $55.8M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.